Metraipolis › archive › dc_f9475ff7039c

Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b… — Europe PMC PMID:42182842

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42182842
DOI
10.1093/ofid/ofag265
License (as archived)
solo-consultazione
Archived
2026-11-02T19:19:46.326Z
SHA-256 of the archived text
dc79d91b1b042ffe6e38d122b77a56b1db2ed22fadfa94bb5a219579e4630b8c
Stable URL of this page
https://metraipolis.com/documento/dc_f9475ff7039c

How to cite

Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b… — Europe PMC PMID:42182842 — Europe PMC (en), https://europepmc.org/article/MED/42182842 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f9475ff7039c (Metraipolis archive dc_f9475ff7039c, sha256 dc79d91b1b042ffe6e38d122b77a56b1db2ed22fadfa94bb5a219579e4630b8c)
BibTeX
@misc{dcf9475ff7039c,
  title = {Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b… — Europe PMC PMID:42182842},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42182842},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f9475ff7039c; sha256 dc79d91b1b042ffe6e38d122b77a56b1db2ed22fadfa94bb5a219579e4630b8c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42182842. Agents can read the archived copy with the MCP tool read_document.